This site is intended only for healthcare professionals resident in the Republic of Ireland




Sign in or RegisterLog out Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up



AboutEfficacySafetyDosingSupport & ResourcesPatient SupportMaterialsVideos

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Refer to section 4.8 of the SmPC for how to report adverse reactions.

Patient Support

Access available resources to help complement your care.

Coming Soon LoadingGroSupport Program


A personalized support program developed in consultation with patient advocacy groups, behavioral psychologists, and healthcare professionals to complement your care. 

Learn about GroSupport

See how GroSupport enlightens, encourages, and empowers patients to take control of their growth hormone treatment.

Multifaceted support for patients throughout their treatment journey​​​​​​​

GroSupport can help your NGENLA patients and their caregivers through the challenges of growth hormone treatment and help them reach their treatment goals. 

After signing up for GroSupport, resources that patients will have access to include:

  • Booklets—Growth hormone disorder—specific disease education and emotional support brochures, available online and as printed booklets you can share
  • Web articles based on the personalized content
  • Online portal—On-demand interactive tools, including a growth tracker, sticker tools, device training, real patient videos, and e-mail alerts
  • Nurse-centric support—Your patients can have access to trained nurses to help them come up with a treatment plan, answer questions, and provide information on topics ranging from disease education and treatment to coping with their condition, addressing concerns, building confidence, and strengthening connections
Sign up online

Please direct patients or their caregivers to sign up online at [insert link]. Patients under the age of 16 will be able to sign up with their caregiver, and have access to the information through their caregiver's account.

Contact your local Pfizer representative to find out how to access and explore the GroSupport website.


If printed booklets are preferred, please request these via [insert link] and distribute to the patient or caregiver appropriately.

Patient Information Leaflet

Access available resources to help complement your care.

Patient Information Leaflet

Click here to view Patient Information Leaflet.1,2


Access data on the efficacy of NGENLA.

View efficacy data

Learn more about clinical safety data of NGENLA in children with GH deficiency.

View safety data

Click here for more information on NGENLA once weekly dosing and administration.

See instructions

Ngenla▼ Prescribing Information

References:Ngenla 24mg pen Patient Information LeafletNgenla 60mg pen Patient Information Leaflet

Back to Top

Legal Category: S1A
Further information is available upon request

PP-NGE-IRL-0019.  Date of Preparation Dec 2022

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.


Copyright © 2023 Pfizer Limited. All rights reserved.

PP-UNP-IRL-0176. January 2023
For Healthcare Professionals in the Republic of Ireland *

The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.

I confirm that I am a healthcare professional resident in the Republic of Ireland.*

I accept and agree to the terms of use.*

If you select 'No', you will be redirected to, where you will be able to access information on Pfizer Healthcare Ireland.

PP-UNP-IRL-0176. January 2023

Yes No
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.